Human monocytes and macrophages differ in their mechanisms of adaptation to hypoxia

Arthritis Research and Therapy

Volumn 14, Issue 4, 2012, Pages

  Fangradt, Monique ^a,b   Hahne, Martin ^a,b,c   Gaber, Timo ^a,b,d   Strehl, Cindy ^a,b   Rauch, Roman ^a   Hoff, Paula ^a,b   Löhning, Max ^a,b   Burmester, Gerd Rüdiger ^a   Buttgereit, Frank ^a,b,d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^c Berlin Brandenburg School for Regenerative Therapies (BSRT)   (Germany)

^d Berlin Brandenburg Center for Regenerative Therapies   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL NUCLEUS; CONTROLLED STUDY; CYTOSOL; CYTOSOLIC FRACTION; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOBLOTTING; MACROPHAGE; MONOCYTE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; ADAPTATION; CELL CULTURE; CELL HYPOXIA; HL 60 CELL LINE; METABOLISM; PHYSIOLOGY; U937 CELL LINE;

ADAPTATION, PHYSIOLOGICAL; CELL HYPOXIA; CELLS, CULTURED; HL-60 CELLS; HUMANS; MACROPHAGES; MONOCYTES; U937 CELLS;

EID: 84864740633     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4011     Document Type: Article

References (42)

1. Ng CT, Biniecka M, Kennedy A, McCormick J, Fitzgerald O, Bresnihan B, Buggy D, Taylor CT, O'Sullivan J, Fearon U, Veale DJ. Synovial tissue hypoxia and inflammation in vivo. Ann Rheum Dis 2010, 69:1389-1395. 10.1136/ard.2009.119776, 2946116, 20439288.
2. Biniecka M, Kennedy A, Fearon U, Ng CT, Veale DJ, O'Sullivan JN. Oxidative damage in synovial tissue is associated with in vivo hypoxic status in the arthritic joint. Ann Rheum Dis 2010, 69:1172-1178. 10.1136/ard.2009.111211, 19706618.
3. Biniecka M, Kennedy A, Ng CT, Chang TC, Balogh E, Fox E, Veale DJ, Fearon U, O'Sullivan JN. Successful tumour necrosis factor (TNF) blocking therapy suppresses oxidative stress and hypoxia-induced mitochondrial mutagenesis in inflammatory arthritis. Arthritis Res Ther 2011, 13:R121. 10.1186/ar3424, 3239359, 21787418.
4. Buttgereit F, Burmester GR, Brand MD. Bioenergetics of immune functions: fundamental and therapeutic aspects. Immunol Today 2000, 21:192-199.
5. Kennedy A, Ng CT, Chang TC, Biniecka M, O'Sullivan JN, Heffernan E, Fearon U, Veale DJ. Tumor necrosis factor blocking therapy alters joint inflammation and hypoxia. Arthritis Rheum 2011, 63:923-932. 10.1002/art.30221, 21225682.
6. Straub RH, Cutolo M, Buttgereit F, Pongratz G. Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases. J Intern Med 2010, 267:543-560. 10.1111/j.1365-2796.2010.02218.x, 20210843.
7. Dziurla R, Gaber T, Fangradt M, Hahne M, Tripmacher R, Kolar P, Spies CM, Burmester GR, Buttgereit F. Effects of hypoxia and/or lack of glucose on cellular energy metabolism and cytokine production in stimulated human CD4+ T lymphocytes. Immunol Lett 2010, 131:97-105. 10.1016/j.imlet.2010.02.008, 20206208.
8. Kolar P, Gaber T, Perka C, Duda GN, Buttgereit F. Human early fracture hematoma is characterized by inflammation and hypoxia. Clin Orthop Relat Res 2011, 469:3118-3126. 10.1007/s11999-011-1865-3, 21409457.
9. Vaupel P, Hockel M, Mayer A. Detection and characterization of tumor hypoxia using pO2 histography. Antioxid Redox Signal 2007, 9:1221-1235. 10.1089/ars.2007.1628, 17536958.
10. Levesque JP, Winkler IG, Hendy J, Williams B, Helwani F, Barbier V, Nowlan B, Nilsson SK. Hematopoietic progenitor cell mobilization results in hypoxia with increased hypoxia-inducible transcription factor-1 alpha and vascular endothelial growth factor A in bone marrow. Stem Cells 2007, 25:1954-1965. 10.1634/stemcells.2006-0688, 17478585.
11. Sahaf B, Atkuri K, Heydari K, Malipatlolla M, Rappaport J, Regulier E, Herzenberg LA. Culturing of human peripheral blood cells reveals unsuspected lymphocyte responses relevant to HIV disease. Proc Natl Acad Sci USA 2008, 105:5111-5116. 10.1073/pnas.0712363105, 2278183, 18364393.
12. Gaber T, Schellmann S, Erekul KB, Fangradt M, Tykwinska K, Hahne M, Maschmeyer P, Wagegg M, Stahn C, Kolar P, Dziurla R, Löhning M, Burmester GR, Buttgereit F. Macrophage migration inhibitory factor counterregulates dexamethasone-mediated suppression of hypoxia-inducible factor-1 alpha function and differentially influences human CD4+ T cell proliferation under hypoxia. J Immunol 2011, 186:764-774. 10.4049/jimmunol.0903421, 21169549.
13. Wang GL, Semenza GL. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA 1993, 90:4304-4308. 10.1073/pnas.90.9.4304, 46495, 8387214.
14. Elbarghati L, Murdoch C, Lewis CE. Effects of hypoxia on transcription factor expression in human monocytes and macrophages. Immunobiology 2008, 213:899-908. 10.1016/j.imbio.2008.07.016, 18926304.
15. Schioppa T, Uranchimeg B, Saccani A, Biswas SK, Doni A, Rapisarda A, Bernasconi S, Saccani S, Nebuloni M, Vago L, Mantovani A, Melillo G, Sica A. Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med 2003, 198:1391-1402. 10.1084/jem.20030267, 2194248, 14597738.
16. Oda T, Hirota K, Nishi K, Takabuchi S, Oda S, Yamada H, Arai T, Fukuda K, Kita T, Adachi T, Semenza GL, Nohara R. Activation of hypoxia-inducible factor 1 during macrophage differentiation. Am J Physiol Cell Physiol 2006, 291:C104-113. 10.1152/ajpcell.00614.2005, 16481368.
17. Battaglia F, Delfino S, Merello E, Puppo M, Piva R, Varesio L, Bosco MC. Hypoxia transcriptionally induces macrophage-inflammatory protein-3alpha/CCL-20 in primary human mononuclear phagocytes through nuclear factor (NF)-kappaB. J Leukoc Biol 2008, 83:648-662.
18. Hartwig JH, Janmey PA. Stimulation of a calcium-dependent actin nucleation activity by phorbol 12-myristate 13-acetate in rabbit macrophage cytoskeletons. Biochim Biophys Acta 1989, 1010:64-71. 10.1016/0167-4889(89)90185-7, 2642389.
19. Semenza GL. Regulation of Metabolism by Hypoxia-Inducible Factor 1. Cold Spring Harb Symp Quant Biol 2011, 76:347-353. 10.1101/sqb.2011.76.010678, 21785006.
20. Palazon A, Aragones Lopez J, Morales-Kastresana A, Ortiz Del Landazuri M, Melero IJ. Molecular Pathways: Hypoxia response in immune cells fighting or promoting cancer. Clin Cancer Res 2011, 18:1207-13.
21. Gaber T, Dziurla R, Tripmacher R, Burmester GR, Buttgereit F. Hypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do!. Ann Rheum Dis 2005, 64:971-980. 10.1136/ard.2004.031641, 1755583, 15800008.
22. Gaber T, Häupl T, Sandig G, Tykwinska K, Fangradt M, Tschirschmann M, Hahne M, Dziurla R, Erekul K, Lautenbach M, Kolar P, Burmester GR, Buttgereit F. Adaptation of human CD4+ T cells to pathophysiological hypoxia: a transcriptome analysis. J Rheumatol 2009, 36:2655-2669. 10.3899/jrheum.090255, 19884271.
23. Hughes JM, Groot AJ, van der Groep P, Sersansie R, Vooijs M, van Diest PJ, Van Noorden CJ, Schlingemann RO, Klaassen I. Active HIF-1 in the normal human retina. J Histochem Cytochem 2010, 58:247-254. 10.1369/jhc.2009.953786, 2825490, 19901273.
24. Martin JL, Charboneau R, Barke RA, Roy S. Chronic morphine treatment inhibits LPS-induced angiogenesis: implications in wound healing. Cell Immunol 2010, 265:139-145. 10.1016/j.cellimm.2010.08.002, 2950783, 20843508.
25. Zhao Q, Du J, Gu H, Teng X, Zhang Q, Qin H, Liu N. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells. Pancreas 2007, 34:242-247. 10.1097/01.mpa.0000250135.95144.b6, 17312464.
26. Bandyopadhyay RS, Phelan M, Faller DV. Hypoxia induces AP-1-regulated genes and AP-1 transcription factor binding in human endothelial and other cell types. Biochim Biophys Acta 1995, 1264:72-78. 10.1016/0167-4781(95)00116-X, 7578260.
27. Oikawa M, Abe M, Kurosawa H, Hida W, Shirato K, Sato Y. Hypoxia induces transcription factor ETS-1 via the activity of hypoxia-inducible factor-1. Biochem Biophys Res Commun 2001, 289:39-43. 10.1006/bbrc.2001.5927, 11708773.
28. Rupec RA, Baeuerle PA. The genomic response of tumor cells to hypoxia and reoxygenation. Differential activation of transcription factors AP-1 and NF-kappa B. Eur J Biochem 1995, 234:632-640. 10.1111/j.1432-1033.1995.632_b.x, 8536713.
29. Schmedtje JF, Ji YS, Liu WL, DuBois RN, Runge MS. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J Biol Chem 1997, 272:601-608. 10.1074/jbc.272.1.601, 8995303.
30. Taylor CT, Furuta GT, Synnestvedt K, Colgan SP. Phosphorylation-dependent targeting of cAMP response element binding protein to the ubiquitin/proteasome pathway in hypoxia. Proc Natl Acad Sci USA 2000, 97:12091-12096. 10.1073/pnas.220211797, 17299, 11035795.
31. Wang GL, Semenza GL. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem 1993, 268:21513-21518.
32. Wiesener MS, Turley H, Allen WE, Willam C, Eckardt KU, Talks KL, Wood SM, Gatter KC, Harris AL, Pugh CW, Ratcliffe PJ, Maxwell PH. Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. Blood 1998, 92:2260-2268.
33. Yao KS, Xanthoudakis S, Curran T, O'Dwyer PJ. Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol Cell Biol 1994, 14:5997-6003. 10.1128/MCB.14.9.5997, 359125, 8065332.
34. Oliver KM, Garvey JF, Ng CT, Veale DJ, Fearon U, Cummins EP, Taylor CT. Hypoxia activates NF-kappaB-dependent gene expression through the canonical signaling pathway. Antioxid Redox Signal 2009, 11:2057-2064. 10.1089/ars.2008.2400, 19422287.
35. Asplund A, Ostergren-Lunden G, Camejo G, Stillemark-Billton P, Bondjers G. Hypoxia increases macrophage motility, possibly by decreasing the heparan sulfate proteoglycan biosynthesis. J Leukoc Biol 2009, 86:381-388. 10.1189/jlb.0908536, 19401393.
36. Burke B, Tang N, Corke KP, Tazzyman D, Ameri K, Wells M, Lewis CE. Expression of HIF-1alpha by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy. J Pathol 2002, 196:204-212. 10.1002/path.1029, 11793372.
37. Frede S, Stockmann C, Freitag P, Fandrey J. Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB. Biochem J 2006, 396:517-527. 10.1042/BJ20051839, 1482811, 16533170.
38. Chang ZL, Beezhold DH. Protein kinase C activation in human monocytes: regulation of PKC isoforms. Immunology 1993, 80:360-366. 1422221, 8288312.
39. Lin YF, Lee HM, Leu SJ, Tsai YH. The essentiality of PKCalpha and PKCbetaI translocation for CD14+monocyte differentiation towards macrophages and dendritic cells, respectively. J Cell Biochem 2007, 102:429-441. 10.1002/jcb.21305, 17455194.
40. Bosco MC, Puppo M, Santangelo C, Anfosso L, Pfeffer U, Fardin P, Battaglia F, Varesio L. Hypoxia modifies the transcriptome of primary human monocytes: modulation of novel immune-related genes and identification of CC-chemokine ligand 20 as a new hypoxia-inducible gene. J Immunol 2006, 177:1941-1955.
41. Roiniotis J, Dinh H, Masendycz P, Turner A, Elsegood CL, Scholz GM, Hamilton JA. Hypoxia prolongs monocyte/macrophage survival and enhanced glycolysis is associated with their maturation under aerobic conditions. J Immunol 2009, 182:7974-7981. 10.4049/jimmunol.0804216, 19494322.
42. Fang HY, Hughes R, Murdoch C, Coffelt SB, Biswas SK, Harris AL, Johnson RS, Imityaz HZ, Simon MC, Fredlund E, Greten FR, Rius J, Lewis CE. Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia. Blood 2009, 114:844-859. 10.1182/blood-2008-12-195941, 2882173, 19454749.